Hexarelin

Hexarelin is a synthetic growth hormone–releasing peptide (GHRP) investigated for its interaction with the ghrelin receptor (GHS-R1a). Research models show that Hexarelin can stimulate growth hormone release in preclinical systems and may influence downstream metabolic pathways, including those related to muscle biology, inflammatory signaling, and lipid metabolism.

Evidence to date is limited to animal and laboratory studies; its effects have not been validated in human populations. Hexarelin is intended strictly for research use and is not approved for clinical or therapeutic applications.

  1. Bowers, C. Y., et al. (1990). Hexarelin, a synthetic hexapeptide, stimulates growth hormone release in vitro and in vivo. Endocrinology.
  2. Locatelli, V., et al. (1994). Metabolic and GH-releasing effects of Hexarelin in laboratory models. European Journal of Endocrinology.
  3. Ghigo, E., et al. (1998). Hexarelin as a GHRP: insights from cellular and animal studies. Hormone Research.
  4. Sun, Y., et al. (2004). Ghrelin receptor pathways and cardiorespiratory effects of GHRP analogs. Cardiovascular Research.
  5. Granata, R., et al. (2002). Hexarelin influences myocardial cell survival and inflammatory cytokine signaling in preclinical systems. Journal of Endocrinological Investigation.
  6. Arvat, E., et al. (1995). Interaction of Hexarelin with GHS-R1a receptors in endocrine research models. Journal of Neuroendocrinology.
  7. Tolle, V., et al. (2001). Growth hormone–releasing peptides and downstream metabolic signaling. Nature Reviews Endocrinology.

*The following findings derive solely from animal and laboratory research. They do not imply effects in human subjects.

  • Growth Hormone Pathways:
Hexarelin has been shown in preclinical studies to stimulate GH release through ghrelin receptor activation.
  • Body Composition Signals:
Animal models suggest possible downstream effects on muscle-related pathways and adipocyte signaling.
  • Cardiovascular Research:
Hexarelin has been explored in laboratory models for potential effects on cardiovascular markers, including myocardial biology and inflammatory mediators.
  • Bone & Connective Tissue Pathways:
Some studies indicate possible influences on bone formation signals and connective tissue pathways via GH-related mechanisms.
  • Lipid & Metabolic Pathways:
Preclinical systems show changes in lipid metabolism markers following Hexarelin administration.
  • Anti-Inflammatory Signaling:
Some laboratory research notes modulation of inflammatory cytokine activity.

$39.00

Per Unit
In stock

Free Shipping on All Orders $1000+